Evidence map›Paper›PMID 32517271›Full record

ReviewJournal of fungi (Basel, Switzerland)2020

Review of Potential

Paulami Chatterjee, Gabriele Sass, Wieslaw Swietnicki, David A Stevens

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. α-Mangostin attenuatesVirulence · 2026
    Article
  2. Article
  3. Role of Iron Availability in ModulatingJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Article
  5. The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuateFrontiers in cellular and infection microbiology · 2025
    Article
  6. Anti-Fungal (Pathogens (Basel, Switzerland) · 2024
    Article
  7. PQS and pyochelin inMicrobiology spectrum · 2024
    Article
  8. Article
  9. Article
  10. Journal of fungi (Basel, Switzerland) · 2023
    Article
  11. The Interkingdom Interaction withJournal of microbiology and biotechnology · 2023
    Article
  12. Sources of Antifungal Drugs.Journal of fungi (Basel, Switzerland) · 2023
    Review
  13. Co-Operative Biofilm Interactions betweenJournal of fungi (Basel, Switzerland) · 2022
    Article
  14. Metrics of Antifungal Effects of Ciprofloxacin onJournal of fungi (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Synergy BetweenFrontiers in cellular and infection microbiology · 2022
    Article
  17. Article
  18. Real-time monitoring ofEmerging microbes & infections · 2021
    Article
  19. Review
  20. FreeingJournal of fungi (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Paulami ChatterjeeCalifornia Institute for Medical Research, San Jose, CA 95128, USA.ORCID 0000-0002-2204-5459
Gabriele SassCalifornia Institute for Medical Research, San Jose, CA 95128, USA.
Wieslaw SwietnickiDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 50-114 Wroclaw, Poland.
David A StevensCalifornia Institute for Medical Research, San Jose, CA 95128, USA.
California Institute for Medical Research · USLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

National Science Center of Poland 2016/21/B/NZ6/02028.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aspergillus fumigatuscystic fibrosisphenazinesPseudomonas aeruginosaPseudomonas–Aspergillus interactionsquinolonesquorum sensingsecretion systemsiderophoresvirulence factors

Identifiers

PMID32517271
PMCPMC7345761
OpenAlexW3033673457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.